clarithromycin has been researched along with Chronic Disease in 169 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 40 (23.67) | 18.2507 |
| 2000's | 70 (41.42) | 29.6817 |
| 2010's | 55 (32.54) | 24.3611 |
| 2020's | 4 (2.37) | 2.80 |
| Authors | Studies |
|---|---|
| Askari, M; Khezri, M; Zoghi, G | 1 |
| Abrams, G; Adolfsson, E; Agarwal, PK; Akkan, AG; Al Alhareth, NS; Alves, VGL; Armentano, R; Bahroos, E; Baig, M; Baldridge, KK; Barman, S; Bartolucci, C; Basit, A; Bertoli, SV; Bian, L; Bigatti, G; Bobenko, AI; Boix, PP; Bokulic, T; Bolink, HJ; Borowiec, J; Bulski, W; Burciaga, J; Butt, NS; Cai, AL; Campos, AM; Cao, G; Cao, Y; Čapo, I; Caruso, ML; Chao, CT; Cheatum, CM; Chelminski, K; Chen, AJW; Chen, C; Chen, CH; Chen, D; Chen, G; Chen, H; Chen, LH; Chen, R; Chen, RX; Chen, X; Cherdtrakulkiat, R; Chirvony, VS; Cho, JG; Chu, K; Ciurlino, D; Coletta, S; Contaldo, G; Crispi, F; Cui, JF; D'Esposito, M; de Biase, S; Demir, B; Deng, W; Deng, Z; Di Pinto, F; Domenech-Ximenos, B; Dong, G; Drácz, L; Du, XJ; Duan, LJ; Duan, Y; Ekendahl, D; Fan, W; Fang, L; Feng, C; Followill, DS; Foreman, SC; Fortunato, G; Frew, R; Fu, M; Gaál, V; Ganzevoort, W; Gao, DM; Gao, X; Gao, ZW; Garcia-Alvarez, A; Garza, MS; Gauthier, L; Gazzaz, ZJ; Ge, RS; Geng, Y; Genovesi, S; Geoffroy, V; Georg, D; Gigli, GL; Gong, J; Gong, Q; Groeneveld, J; Guerra, V; Guo, Q; Guo, X; Güttinger, R; Guyo, U; Haldar, J; Han, DS; Han, S; Hao, W; Hayman, A; He, D; Heidari, A; Heller, S; Ho, CT; Ho, SL; Hong, SN; Hou, YJ; Hu, D; Hu, X; Hu, ZY; Huang, JW; Huang, KC; Huang, Q; Huang, T; Hwang, JK; Izewska, J; Jablonski, CL; Jameel, T; Jeong, HK; Ji, J; Jia, Z; Jiang, W; Jiang, Y; Kalumpha, M; Kang, JH; Kazantsev, P; Kazemier, BM; Kebede, B; Khan, SA; Kiss, J; Kohen, A; Kolbenheyer, E; Konai, MM; Koniarova, I; Kornblith, E; Krawetz, RJ; Kreouzis, T; Kry, SF; Laepple, T; Lalošević, D; Lan, Y; Lawung, R; Lechner, W; Lee, KH; Lee, YH; Leonard, C; Li, C; Li, CF; Li, CM; Li, F; Li, J; Li, L; Li, S; Li, X; Li, Y; Li, YB; Li, Z; Liang, C; Lin, J; Lin, XH; Ling, M; Link, TM; Liu, HH; Liu, J; Liu, M; Liu, W; Liu, YP; Lou, H; Lu, G; Lu, M; Lun, SM; Ma, Z; Mackensen, A; Majumdar, S; Martineau, C; Martínez-Pastor, JP; McQuaid, JR; Mehrabian, H; Meng, Y; Miao, T; Miljković, D; Mo, J; Mohamed, HSH; Mohtadi, M; Mol, BWJ; Moosavi, L; Mosdósi, B; Nabu, S; Nava, E; Ni, L; Novakovic-Agopian, T; Nyamunda, BC; Nyul, Z; Önal, B; Özen, D; Özyazgan, S; Pajkrt, E; Palazon, F; Park, HW; Patai, Á; Patai, ÁV; Patzke, GR; Payette, G; Pedoia, V; Peelen, MJCS; Pellitteri, G; Peng, J; Perea, RJ; Pérez-Del-Rey, D; Popović, DJ; Popović, JK; Popović, KJ; Posecion, L; Povall, J; Prachayasittikul, S; Prachayasittikul, V; Prat-González, S; Qi, B; Qu, B; Rakshit, S; Ravelli, ACJ; Ren, ZG; Rivera, SM; Salo, P; Samaddar, S; Samper, JLA; Samy El Gendy, NM; Schmitt, N; Sekerbayev, KS; Sepúlveda-Martínez, Á; Sessolo, M; Severi, S; Sha, Y; Shen, FF; Shen, X; Shen, Y; Singh, P; Sinthupoom, N; Siri, S; Sitges, M; Slovak, JE; Solymosi, N; Song, H; Song, J; Song, M; Spingler, B; Stewart, I; Su, BL; Su, JF; Suming, L; Sun, JX; Tantimavanich, S; Tashkandi, JM; Taurbayev, TI; Tedgren, AC; Tenhunen, M; Thwaites, DI; Tibrewala, R; Tomsejm, M; Triana, CA; Vakira, FM; Valdez, M; Valente, M; Valentini, AM; Van de Winckel, A; van der Lee, R; Varga, F; Varga, M; Villarino, NF; Villemur, R; Vinatha, SP; Vincenti, A; Voskamp, BJ; Wang, B; Wang, C; Wang, H; Wang, HT; Wang, J; Wang, M; Wang, N; Wang, NC; Wang, Q; Wang, S; Wang, X; Wang, Y; Wang, Z; Wen, N; Wesolowska, P; Willis, M; Wu, C; Wu, D; Wu, L; Wu, X; Wu, Z; Xia, JM; Xia, X; Xia, Y; Xiao, J; Xiao, Y; Xie, CL; Xie, LM; Xie, S; Xing, Z; Xu, C; Xu, J; Yan, D; Yan, K; Yang, S; Yang, X; Yang, XW; Ye, M; Yin, Z; Yoon, N; Yoon, Y; Yu, H; Yu, K; Yu, ZY; Zhang, B; Zhang, GY; Zhang, H; Zhang, J; Zhang, M; Zhang, Q; Zhang, S; Zhang, W; Zhang, X; Zhang, Y; Zhang, YW; Zhang, Z; Zhao, D; Zhao, F; Zhao, P; Zhao, W; Zhao, Z; Zheng, C; Zhi, D; Zhou, C; Zhou, FY; Zhu, D; Zhu, J; Zhu, Q; Zinyama, NP; Zou, M; Zou, Z | 1 |
| Han, M; Hu, X; Li, H; Shu, H; Wang, Y; Wen, W; Xu, H; Yu, Z; Zhang, J | 1 |
| Akbaş, T; Şenocak Taşçı, E | 1 |
| Ho, NH; Hsu, AT; Lin, CF; Merton, AT; Wang, MC; Wang, YP; Wu, PS | 1 |
| Ishinaga, H; Shah, SA; Takeuchi, K | 1 |
| Chen, F; Deng, J; Fu, Q; Lai, Y; Luo, Q; Ou, C; Shi, J; Xu, R | 1 |
| Benedeto-Stojanov, D; Grgov, S; Radovanović-Dinić, B; Tasić, T | 1 |
| Elsner, P; Kranzer, K; Rässler, F; Schliemann, S; Tittelbach, J; Zollmann, C | 1 |
| Álvarez-Pantoja, E; Gallardo-Montoya, JM; Gallardo-Wong, I; Guerrero-Rivera, S; Gutiérrez-Espíndola, G; Maillón-García, LA; Medrano-Contreras, J; Morán-Villota, S | 1 |
| Chang, YW; Cho, JH; Jang, JY; Kim, JW; Ko, WJ; Moon, JR; Oh, CH; Oh, SJ; Park, YM | 1 |
| Baba, S; Fukuoka, K; Horikoshi, Y; Kamada, K; Kanemaru, A; Kikuchi, K; Myojin, S; Okamoto, Y; Suzuki, H; Yoshida, A | 1 |
| Ando, M; Hirano, T; Kadota, JI; Ono, T; Tokimatsu, I; Usagawa, Y; Yoshikawa, H | 1 |
| Cao, PP; Liao, B; Liu, JX; Liu, Z; Long, XB; Ma, J; Ning, Q; Wang, H; Zeng, M | 1 |
| Akashi, K; Katsunuma, T; Sugimura, K; Suzuki, R | 1 |
| Huang, Z; Zhou, B | 1 |
| Berende, A; Evers, AWM; Kessels, RPC; Kullberg, BJ; Ter Hofstede, HJM; van Middendorp, H; Vogelaar, ML; Vos, FJ | 1 |
| Beard, D; Blackshaw, H; Boardman, J; Carpenter, J; Clarke, CS; Cook, J; Denaxas, S; Durham, S; Hopkins, C; le Conte, S; Little, P; Lund, V; Morris, S; Philpott, C; Schilder, A; Sones, W; Thomas, M; Vennik, J | 1 |
| Abebe, W; Moges, F; Molla, R; Tiruneh, M | 1 |
| Bhargava, SK; Peethambaran, K | 1 |
| Johari, P; Najafipour, R; Naserpour Farivar, T | 1 |
| Abbas, Z; Awan, S; Hamid, S; Jafri, F; Jafri, W; Naz, S; Usman, MW; Yakoob, J | 1 |
| Bastaninejad, S; Dabirmoghaddam, P; Mehdizadeh Seraj, J; Meighani, A; Mokhtari, Z | 1 |
| Ding, M; Fan, Y; Hong, H; Li, H; Luo, Q; Lv, M; Shi, J; Xia, W; Xu, R | 1 |
| Lopatin, A; Varvyanskaya, A | 1 |
| Deng, J; Li, H; Luo, Q; Shi, J; Xu, R; Zuo, K | 1 |
| Kato, M | 1 |
| Bani-Sadr, F; Boulagnon, C; Diebold, MD; Hentzien, M; Jaussaud, R; Lambert, D; Nguyen, Y; Ramaholimihaso, F; Rouger, C | 1 |
| Furleta, VV; Nykula, TD | 1 |
| Chen, C; Cui, Y; Hu, S; Liu, Z; You, X | 1 |
| Gerek, M; Gumral, R; Kilic, A; Polat, B; Tosun, F; Yildizoglu, U | 1 |
| Asaoka, D; Ito, M; Kawai, T; Kawakami, K; Kurihara, N; Masaoaka, T; Matsuhisa, T; Mine, T; Mizuno, S; Nagahara, A; Nishizawa, T; Ohkusa, T; Omata, F; Sakaki, N; Sasaki, H; Suzuki, H; Suzuki, M; Takahashi, S; Tokunaga, K; Torii, A | 1 |
| Gianni, C | 1 |
| Cao, PP; Cui, YH; Li, ZY; Liu, Z; Ma, J; Wang, H; Zeng, M | 1 |
| Matsumoto, T; Otsuka, K; Tomii, K | 1 |
| Curth, HM; Dinter, J; Hunzelmann, N; Kütting, F; Nigemeier, K; Steffen, HM | 1 |
| Shimizu, T; Suzaki, H | 1 |
| Ahmed, MR; Mel-Hennawi, D | 1 |
| Ahmed, S; Bewick, J; Carrie, S; Erskine, S; Hopkins, C; Morris, S; Philpott, CM; Sama, A; Sunkaraneni, V; Woods, J | 1 |
| Steurer, J | 1 |
| Alarcón-Millán, J; Betancourt-Linares, R; Castañón-Sánchez, CA; Cortés-Malagón, EM; Cruz-Del Carmen, I; De Sampedro-Reyes, J; Fernández-Tilapa, G; Román-Román, A | 1 |
| Cervin, A; Coman, WB; Greiff, L; Mackay-Sim, A; Wallwork, B | 1 |
| Fukami, S; Haruna, S; Moriyama, H; Ozawa, M; Shimada, C | 1 |
| Esedov, EM; Magomedéminova, AS | 1 |
| Amendola, G; Baronci, C; Battisti, L; Bisogno, G; Branciforte, F; Ceppi, S; Corti, A; De Mattia, D; Farruggia, P; Giordano, P; Jankovic, M; Matarese, SM; Miraglia, V; Nardi, M; Nobili, B; Notarangelo, L; Palazzi, G; Parodi, E; Ramenghi, U; Russo, G; Tucci, F; Zecca, M | 1 |
| Hirai, T; Kikuchi, R; Matsukura, T; Mino, N; Okamoto, T | 1 |
| Li, L; Shi, X; Wang, S; Zhou, B | 1 |
| Harada, T; Haruna, S; Hirakawa, K; Ichimura, K; Kase, Y; Kawauchi, H; Kurono, Y; Majima, Y; Moriyama, H; Naito, K; Suzaki, H; Takeuchi, K | 1 |
| Chen, F; Chen, R; Fan, Y; Fu, Q; Li, H; Li, Z; Liu, W; Liu, Z; Luo, Q; Shi, J; Xu, G; Xu, R; Xu, Y; Zuo, K | 1 |
| Feng, Z; Hong, Y; Li, Q; Li, X; Liu, J; Liu, L; Lu, X; Wan, Y; Zhong, G | 1 |
| El-Halabi, M; Ghaith, O; Hashash, JG; Maasri, K; Malli, A; Mansour, NM; Sharara, AI; Sukkarieh, I | 1 |
| Ben Mahmoud, L; Ghozzi, H; Hakim, A; Sahnoun, Z; Zeghal, K | 1 |
| Hwang, JH; Jeong, SH; Jo, HJ; Jung, HC; Kim, JM; Kim, JW; Kim, JY; Kim, N; Lee, DH; Lee, JH; Lee, SH; Nam, RH; Park, HK; Park, YS; Shin, CM; Song, IS | 1 |
| Kuian, IuS; Mokronosova, MA | 1 |
| Ding, H; Gao, M; Li, Q; Lu, J; Wang, H; Wang, Z; Zhong, G | 1 |
| Celik, HH; Korkmaz, H; Ocal, B; Ozdek, A; Saylam, G; Tatar, EÇ; Tatar, I | 1 |
| Belousova, NL; Firsova, LD; Goncharenko, LS; Govorun, VM; Ianova, OB; Kashnikov, VS; Kim, VA; Masharova, AA; Shcherbakov, PL; Shcherbakova, MIu | 1 |
| Bobacheva, TIu; Piskunov, GZ | 1 |
| Al-Mot, S; Bergeron, C; Dubois, Y; Morisset, J; Ptaszynski, S | 1 |
| Hamajima, Y; Hashiba, M; Murakami, S; Nakamura, Y; Nakayama, M; Ohno, N; Ozaki, S; Suzuki, M; Yokota, M | 1 |
| Ang, D; Ang, TL; Chiam, P; Fock, KM; Teo, EK; Wang, L | 1 |
| Andersen, AB; Iversen, M; Katzenstein, TL; Lillebaek, T; Mared, L; Qvist, T | 1 |
| Kondo, M; Nagai, A; Tagaya, E; Tamaoki, J | 1 |
| Halpern, MT; Kirsch, J; Palmer, CS; Zodet, M | 1 |
| Asaka, M; Shimodan, M; Sugiyama, T; Tsuchida, M; Yokota, K | 1 |
| Bettoni, L; Cattaneo, R; Rizzini, FL; Tosoni, C | 1 |
| Andou, I; Enomoto, F; Ichikawa, G; Nagaoka, I | 1 |
| Sugiyama, Y | 1 |
| Cervin, A; Coman, W; Feron, F; Mackay-Sim, A; Wallwork, B | 1 |
| Barsić, B; Cajić, V; Krhen, I; Mareković, I; Markovinović, L; Roglić, S; Schönwald, S; Skerk, V; Vince, A; Zeljko, Z | 1 |
| Freudenstein, J; Hauke, W; Henneicke-Von Zepelin, HH; Köhler, G | 1 |
| Maeda, K; Mikasa, K | 1 |
| Odagiri, S; Shimada, J; Takahashi, H; Watanuki, Y | 1 |
| Ichinomiya, K; Suzuki, M; Watanabe, T | 1 |
| Ishimitsu, R; Iwamoto, J; Kataoka, S; Kawauchi, H; Ogasawara, K; Tagami, H | 1 |
| Cervin, A; Coman, W; Mackay-Sim, A; Wallwork, B | 1 |
| Gotfried, MH | 1 |
| Ferguson, BJ | 1 |
| Aish, L; Gaur, S; Trayner, E; Weinstein, R | 1 |
| Fujioka, T; Kodama, M; Miyajima, H; Murakami, K; Nasu, M; Ogata, M; Ohtsuka, E; Okimoto, T; Saburi, Y; Sato, R; Watanabe, K | 1 |
| Amsden, GW | 1 |
| Gunaid, AA; Hassan, NA; Murray-Lyon, IM | 1 |
| Cho, YK; Jeon, WK; Keum, DK; Kim, BI; Kim, HJ; Kim, SH; Park, DI; Park, SH; Sohn, CI; Sung, IK | 1 |
| Ignat'ev, VK; Karel'skaia, IA | 1 |
| Bartucci, F; Bohórquez, P; Ortega, C; Pellegrino, FA; Schlaen, A; Wainberg, P | 1 |
| Bjarnason, IT; Charlett, A; Dobbs, RJ; Dobbs, SM; Ibrahim, MA; Kerwin, RW; Mahler, RF; Oxlade, NL; Peterson, DW; Plant, JM; Price, AB; Weller, C | 1 |
| Asano, K; Gyo, H; Heisha, Y; Higashiyama, Y; Kaneko, Y; Kawano, S; Miyazaki, Y; Monda, J; Ono, H; Tashiro, T; Yanagihara, K | 1 |
| Cho, YS; Kim, SS; Konkin, TA; Meitner, P; Moss, SF; Resnick, MB | 1 |
| Chang, J; de Wet, R; Fogarty, C; Mandell, L; Nusrat, R; Rangaraju, M | 1 |
| Klatka, J; Obszańska, B; Polberg, K; Remer, M | 1 |
| Chan, AO; Chan, CK; Cheung, HK; Kwong, YL; Lai, KC; Lam, SK; Peng, JZ; Rashid, A; Wong, BC; Yuen, MF | 1 |
| Anzueto, A; Choudhri, S; Haverstock, D; Kureishi, A; Niederman, MS; Perroncel, R; Sethi, S | 1 |
| Izumi, S; Taniguchi, H | 1 |
| Higashiyama, Y; Higuchi, N; Hirakata, Y; Kadota, J; Kohno, S; Kuroki, M; Miyazaki, Y; Mizuta, Y; Mukae, H; Ohno, H; Tomono, K; Tsukamoto, K; Yanagihara, K | 1 |
| Kumala, W; Rani, A | 1 |
| Ferekidis, E; Maragoudakis, P; Nikolopoulos, TP; Tzagaroulakis, A; Vlastarakos, PV | 1 |
| Heijboer, H; Neefjes, VM; Tamminga, RY | 1 |
| Chen, XY; Ge, ZZ; Li, XB; Liu, WZ | 1 |
| Barbatzas, C; Demonakou, M; Giamarellos-Bourboulis, EJ; Giamarellou, H; Koussoulas, V; Spyridaki, E; Vaki, I; Vassiliou, S | 1 |
| Magen, E; Mishal, J; Scharf, S; Schlesinger, M | 1 |
| Ali, M; Whitehead, M | 1 |
| Cervin, A; Wallwork, B | 1 |
| Bisogno, G; Carli, M; Colleselli, P; Da Dalt, L; Errigo, G; Grotto, P; Pusiol, A; Rossetti, F; Sainati, L | 1 |
| Arzanian, MT; Gachkar, L; Hamidieh, AA; Pasha, F | 1 |
| Amenta, PS; Das, KK; Das, KM; Geng, X; Kohgo, Y; Lin, JJ; Tanabe, H; Tanaka, A; Watari, J | 1 |
| Hishikari, K; Isobe, M; Ogawa, M; Suzuki, J; Takayama, K; Tanaka, H | 1 |
| Konno, K; Tagaya, E; Takeyama, K; Tamaoki, J | 1 |
| Michałowska-Mitczuk, D | 1 |
| Tomono, K | 1 |
| Ohgaki, N | 1 |
| Demartini, G; Dugnani, S; Ferrara, F; Fraschini, F; Scaglione, F; Triscari, F | 1 |
| Blanco, S; de Vega, T; López, C; Pascual, E; Sánchez, M; Zamarrón, A | 1 |
| Hosie, J; Quinn, P; Sides, G; Smits, P | 1 |
| Odagiri, S | 1 |
| Amemiya, T; Fujimura, M; Matsuda, T; Mizuguchi, M; Myou, S; Nishi, K; Ooka, T; Tachibana, H | 1 |
| Ferguson, PJ; Saulsbury, FT | 1 |
| Hirakata, Y; Kadota, J; Koga, H; Kohno, S; Sawai, T; Tashiro, T; Tomono, K; Yanagihara, K | 1 |
| Brady, RC; Goderwis, D; Mayer, T; Schleiss, MR; Sheth, A | 1 |
| Ikemura, N; Imoto, I; Misaki, M; Nakao, K; Shibata, T; Taguchi, Y; Takaji, S; Yamauchi, K; Yamazaki, N | 1 |
| Abraira, V; Alvarez Baleriola, I; Boixeda, D; Ceña, G; García Plaza, A; Gisbert, JP; Martín de Argila, C; Mur, M | 1 |
| Ebina, K; Kato, S; Naganuma, H; Takeyama, J | 1 |
| Carnicer, J | 1 |
| Bei, L; Chen, S; Chen, Z | 1 |
| Furuta, S; Iwamoto, M; Matsuoka, H; Oyama, K; Sugihara, J | 1 |
| Iino, Y; Miyazawa, T; Shiga, J | 1 |
| Ando, I; Enomoto, F; Ichikawa, G; Kin, R | 1 |
| Baba, S; Hashiba, M; Miyamoto, N | 1 |
| Iino, Y; Kakinuma, M; Kishimoto, H; Miyazawa, T; Ogawa, K; Shiga, J | 1 |
| Fujita, K; Majima, Y; Sakakura, Y; Shimizu, T; Usui, T | 1 |
| Anzueto, A; Barkman, HW; Chodosh, S; Kowalsky, S; Moesker, H; Schreurs, A; Shan, M; Siami, G; Stack, T | 1 |
| Pigatto, P; Valsecchi, R | 1 |
| de Lange, J; Lindeboom, JA; van den Akker, HP | 1 |
| Arosio, C; Bertinieri, G; Blasi, F; Ceriani, G; Cosentini, R; Mandelli, C; Perondi, R; Ranzi, ML; Tarsia, P; Tien, TV; Torgano, G | 1 |
| Lipsky, BA; Talbot, GH; Townsend, L; Unowsky, J; Zhang, H | 1 |
| Furunishi, M; Kita, E; Maeda, K; Mashima, T; Mikasa, K; Narita, N; Sakamoto, M; Ueta, K | 1 |
| Ballard, ED; Fennerty, MB; Talley, NJ; Vakil, N | 1 |
| Allan, GS; Davis, W; Foster, SF; Malik, R; Martin, P; Mitchell, DH | 1 |
| Mach, T; Zahradnik-Bilska, J | 1 |
| Ali, A; Awad, CE; Dainesi, SM; Matyas, R; Nakatani, J; Rocha, RT; Salazar, MS; Silva, CO; Vital, AC | 1 |
| Ballow, CH; Forrest, A; Hyatt, JM; Peloquin, CA; Sands, MF; Schentag, JJ; Tran, JQ | 1 |
| Boyanova, L; Katzarov, N; Koumanova, R; Mitov, I; Spassova, Z; Stancheva, I | 1 |
| Arima, S; Jinn, TH; Jung, HW; Majima, Y; Min, YG; Rhee, CS; Sakakura, Y | 1 |
| Fujita, K; Majima, Y; Sakakura, Y; Shimizu, T | 1 |
| Higashiyama, Y; Hirakata, Y; Kadota, J; Kaneko, Y; Kohno, S; Kuroki, M; Maesaki, S; Miyazaki, Y; Ohno, H; Sawai, T; Tashiro, T; Tomono, K; Yanagihara, K | 1 |
| Daudén, E; García-Díez, A; Jiménez-Alonso, I | 1 |
| Colin, AA | 1 |
| Möhlen, S; Witthaut, J | 1 |
| Asaoka, N; Honda, Y; Ohba, H; Okimoto, N; Osaki, K; Soejima, R; Sunagawa, T; Yoneyama, H | 1 |
| Adamakis, I; Giamarellos-Bourboulis, EJ; Giamarellou, H; Giannopoulos, A; Koratzanis, G; Panou, C | 1 |
| Adler, JL; Jannetti, W; Notario, G; Palmer, R; Schneider, D; Zhang, J | 1 |
| Iino, Y; Kojima, C; Miyazawa, T; Sasaki, Y | 1 |
| Hashiba, M; Kondo, K; Koseki, A; Miyamoto, N; Murakami, S; Suzuki, Y | 1 |
| Kondo, M; Nagai, A; Nakada, J; Tagaya, E; Tamaoki, A | 1 |
| Konishi, Y; Mikasa, K; Murakawa, Y; Murata, N; Narita, N; Sasaki, Y; Tsujiuchi, T; Tsutsumi, M | 1 |
| Ashorn, M; Mäkipernaa, A; Ruuska, T | 1 |
| Kroegel, C; Mock, B; Rödel, J | 1 |
| Fukushima, K; Honda, I; Nanba, K; Naoe, H; Shirakawa, T; Sugimoto, M | 1 |
| Furukawa, F; Sakurane, M; Shiotani, A | 1 |
| Hirakata, Y; Imamura, Y; Kadota, J; Kaneko, Y; Kohno, S; Kuroki, M; Miyazaki, Y; Mukae, H; Sawai, T; Tomono, K; Yanagihara, K | 1 |
| Ball, P; Mandell, L; Schentag, JJ; Wilson, R | 1 |
| Ateşkan, U; Mas, MR; Ozdemir, A; Sağlamkaya, U; Sahin, S | 1 |
| Burrascano, J; Stricker, RB; Winger, E | 1 |
| Hamada, K; Kita, E; Konishi, M; Kunimatsu, M; Maeda, K; Masutani, T; Mikasa, K; Sano, R; Sawaki, M; Takeuchi, S | 1 |
| Araujo, FG; Lin, T; Prokocimer, P; Remington, JS | 1 |
| Craft, JC; Guay, DR | 1 |
| Aldons, PM | 1 |
| Bachand, RT | 1 |
15 review(s) available for clarithromycin and Chronic Disease
| Article | Year |
|---|---|
Topics: Acetylcholine; Acinetobacter baumannii; Actinobacteria; Action Potentials; Adalimumab; Adaptation, Physiological; Adipates; Administration, Oral; Adolescent; Adrenal Glands; Adsorption; Adult; Aged; Aged, 80 and over; Aging; AIDS-Related Opportunistic Infections; Aldosterone; Amino Acids; Ammonia; Amoxicillin; AMP-Activated Protein Kinases; Animals; Antacids; Anti-Bacterial Agents; Antineoplastic Agents; Antirheumatic Agents; Apgar Score; Area Under Curve; ARNTL Transcription Factors; Arterial Pressure; Arthritis, Juvenile; Athletes; Attention; Biodegradation, Environmental; Biofilms; Biofuels; Biological Therapy; Biomass; Biomimetic Materials; Bioreactors; Birth Weight; Bismuth; Blood Flow Velocity; Bone and Bones; Brain Injuries, Traumatic; Calcium; Calcium Channels; Capsaicin; Carbon; Carcinoma, Hepatocellular; Cardiomegaly, Exercise-Induced; Cartilage; Cartilage, Articular; Case-Control Studies; Catalysis; Cats; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Death; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Charcoal; Chemokine CCL2; Child; Child, Preschool; Chondrogenesis; Chronic Disease; Circadian Clocks; Circadian Rhythm Signaling Peptides and Proteins; Clarithromycin; Coccidioides; Coccidioidomycosis; Cognitive Behavioral Therapy; Coinfection; Color; Coloring Agents; Computer Simulation; Computers, Molecular; Consensus; Corticosterone; Cyclic AMP Response Element-Binding Protein; Cytochrome P-450 Enzyme System; Death, Sudden, Cardiac; Density Functional Theory; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Dialysis Solutions; Disease Models, Animal; Dogs; Dopamine Agonists; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Electrocardiography; Electrocardiography, Ambulatory; Electrolytes; Endocardium; Endocrine Disruptors; Endocytosis; Endoscopy, Gastrointestinal; Escherichia coli Proteins; Esters; Evolution, Molecular; Executive Function; Feasibility Studies; Female; Ferric Compounds; Fluorescence; Fluorescent Dyes; Fluorine Radioisotopes; Frailty; Free Radical Scavengers; Gabapentin; Geriatric Assessment; Glucaric Acid; Glucocorticoids; Glucose; Glucose Metabolism Disorders; Halogenated Diphenyl Ethers; Heart Rate; Heart Ventricles; HEK293 Cells; Helicobacter Infections; Helicobacter pylori; Hep G2 Cells; Hepatocytes; Humans; Hungary; Hydrogen Sulfide; Hydrogen-Ion Concentration; Immunologic Factors; Immunomodulation; Immunosuppressive Agents; Independent Living; Indocyanine Green; Infant; Infant Formula; Infant Mortality; Infant, Newborn; Infant, Newborn, Diseases; Inflorescence; Insulin Resistance; Insulins; International Agencies; Iron; Isotonic Solutions; Kidney Failure, Chronic; Kinetics; Lactones; Leukocytes, Mononuclear; Liver Neoplasms; Macular Edema; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetosomes; Male; Medical Audit; Mesenchymal Stem Cells; Metabolic Syndrome; Metformin; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Middle Aged; Molecular Conformation; Molecular Targeted Therapy; Motor Activity; Multiple Sclerosis; Mycophenolic Acid; Netherlands; Neuropsychological Tests; Nuclear Energy; Organs at Risk; Osteoarthritis; Osteoarthritis, Hip; Oxidation-Reduction; Palladium; Pericardium; Perinatal Death; Peritoneal Dialysis; Phantoms, Imaging; Pharmaceutical Preparations; Phospholipids; Phosphorylation; Physical Conditioning, Human; Physical Endurance; Pilot Projects; Polyketides; Polymers; Positron-Emission Tomography; Postoperative Period; Potassium; Powders; Pramipexole; Predictive Value of Tests; Pregabalin; Pregnancy; Pregnancy Outcome; Protein Structure, Secondary; Proton Pump Inhibitors; Puberty; Pulmonary Circulation; Quality Assurance, Health Care; Quantum Dots; Radiometry; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Rats, Sprague-Dawley; Receptors, CCR2; Receptors, Transferrin; Regeneration; Registries; Renal Insufficiency, Chronic; Reproducibility of Results; Research Design; Restless Legs Syndrome; Retina; Retinoid X Receptor alpha; Retrospective Studies; Rhenium; Risk Factors; RNA, Messenger; Severity of Illness Index; Sex Factors; Sodium; Sodium Fluoride; Solvents; Spectrometry, Fluorescence; Spectroscopy, Fourier Transform Infrared; Stereoisomerism; Stroke; Structure-Activity Relationship; Tachycardia, Ventricular; Tetracycline; Tetrahydrofolate Dehydrogenase; Tetrahydronaphthalenes; Thermodynamics; Thiophenes; Time Factors; Tinidazole; Tomography, Optical Coherence; Tomography, X-Ray Computed; Topiramate; Toxoplasma; Toxoplasmosis, Cerebral; Transferrin; Treatment Outcome; Up-Regulation; Upper Extremity; Uremia; Uveitis; Vascular Remodeling; Ventricular Fibrillation; Ventricular Function, Left; Ventricular Function, Right; Ventricular Remodeling; Verapamil; Veterans; Visual Acuity; Vitrectomy; Water Pollutants, Chemical; Zea mays; Zirconium | 2019 |
Clarithromycin for the treatment of adult chronic rhinosinusitis: a systematic review and meta-analysis.
Topics: Administration, Intranasal; Administration, Oral; Adult; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Glucocorticoids; Humans; Nasal Lavage; Nasal Sprays; Randomized Controlled Trials as Topic; Rhinitis; Sinusitis; Sodium Chloride | 2019 |
[Expanded indication of National Health Insurance for H. pylori associated gastritis].
Topics: Amoxicillin; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Metronidazole; National Health Programs; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Stomach Neoplasms | 2014 |
Past, present and future of macrolide therapy for chronic rhinosinusitis in Japan.
Topics: Anti-Bacterial Agents; Azithromycin; Bronchiolitis; Chronic Disease; Clarithromycin; Erythromycin; Haemophilus Infections; History, 20th Century; History, 21st Century; Humans; Japan; Macrolides; Nasal Polyps; Rhinitis; Sinusitis | 2016 |
A randomized trial of standard-dose versus half-dose rabeprazole, clarithromycin, and amoxicillin in the treatment of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Rabeprazole | 2011 |
[Contribution of Japanese researchers to progress in the field of pulmonary medicine in the last 100 years: New pharmacological action of macrolides].
Topics: Anti-Bacterial Agents; Azithromycin; Bronchiolitis; Chronic Disease; Clarithromycin; Erythromycin; History, 20th Century; Humans; Japan; Lung Neoplasms; Respiratory Tract Infections | 2002 |
Macrolides for the treatment of chronic sinusitis, asthma, and COPD.
Topics: Anti-Bacterial Agents; Asthma; Chronic Disease; Clarithromycin; Clinical Trials as Topic; Humans; Immunologic Factors; Pulmonary Disease, Chronic Obstructive; Sinusitis | 2004 |
Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Azithromycin; Chronic Disease; Clarithromycin; Community-Acquired Infections; Erythromycin; Humans; Inflammation; Macrolides; Respiratory Tract Infections | 2005 |
Eradication of H. influenzae in AECB: A pooled analysis of moxifloxacin phase III trials compared with macrolide agents.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; Azithromycin; Bronchitis, Chronic; Chronic Disease; Clarithromycin; Clinical Trials, Phase III as Topic; Double-Blind Method; Female; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Middle Aged; Moxifloxacin; Multicenter Studies as Topic; Quinolines; Randomized Controlled Trials as Topic; Treatment Outcome | 2006 |
Biofilms in ear, nose, and throat infections: how important are they?
Topics: Anti-Bacterial Agents; Bacterial Infections; Biofilms; Chronic Disease; Clarithromycin; Cochlear Implants; Combined Modality Therapy; Erythromycin; Foreign Bodies; Humans; Middle Ear Ventilation; Otitis Media with Effusion; Pharynx; Phenotype; Prosthesis-Related Infections; Sinusitis | 2007 |
Macrolide therapy of chronic rhinosinusitis.
Topics: Anti-Bacterial Agents; Biofilms; Chemotaxis, Leukocyte; Chronic Disease; Clarithromycin; Erythromycin; Humans; Macrolides; Rhinitis; Roxithromycin; Sinusitis | 2007 |
[Patients with chronic sputum positive tuberculosis-a therapeutic problem].
Topics: Amikacin; Amoxicillin; Antitubercular Agents; Chronic Disease; Clarithromycin; Clofazimine; Humans; Rifabutin; Sputum; Tuberculosis, Pulmonary | 1995 |
Facial sporotrichoid infection with Mycobacterium marinum.
Topics: Administration, Oral; Anti-Bacterial Agents; Child, Preschool; Chronic Disease; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Facial Dermatoses; Humans; Male; Mycobacterium Infections, Nontuberculous; Rifampin; Sporotrichosis | 1997 |
[Clinical application of the new action of macrolide preparations to respiratory diseases].
Topics: Anti-Bacterial Agents; Bacterial Infections; Bronchiectasis; Bronchitis; Chronic Disease; Clarithromycin; Erythromycin; Humans; Immunologic Factors; Lung Neoplasms | 1999 |
Helicobacter pylori and idiopathic chronic urticaria.
Topics: Adult; Age Factors; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Carbon Isotopes; Case-Control Studies; Chronic Disease; Clarithromycin; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prevalence; Turkey; Urea; Urticaria | 2000 |
60 trial(s) available for clarithromycin and Chronic Disease
| Article | Year |
|---|---|
Introducing a Novel Combination Therapy with Macrolides for the Treatment of Chronic Rhinosinusitis: A Randomized Controlled Trial.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Chronic Disease; Clarithromycin; Humans; Macrolides; Rhinitis; Single-Blind Method; Sinusitis; Treatment Outcome | 2022 |
Add-on effect of clarithromycin to oral steroids as post- operative therapy for chronic rhinosinusitis with nasal polyps: a randomised controlled trial.
Topics: Chronic Disease; Clarithromycin; Endoscopy; Humans; Nasal Polyps; Rhinitis; Steroids; Treatment Outcome | 2020 |
Lack of additional effects of long-term, low-dose clarithromycin combined treatment compared with topical steroids alone for chronic rhinosinusitis in China: a randomized, controlled trial.
Topics: Administration, Topical; Adult; Anti-Bacterial Agents; Budesonide; China; Chronic Disease; Clarithromycin; Cytokines; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nasal Polyps; Nasal Sprays; Rhinitis; Single-Blind Method; Sinusitis; Treatment Outcome; Young Adult | 2018 |
Can probiotics improve efficiency and safety profile of triple Helicobacter pylori eradication therapy? A prospective randomized study.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Biopsy; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Probiotics; Prospective Studies; Proton Pump Inhibitors; Serbia; Time Factors; Treatment Outcome; Young Adult | 2016 |
Comparison of efficacy of fluticasone propionate versus clarithromycin for postoperative treatment of different phenotypic chronic rhinosinusitis: a randomized controlled trial.
Topics: Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Fluticasone; Humans; Nasal Polyps; Prospective Studies; Rhinitis; Single-Blind Method; Sinusitis | 2019 |
Effect of prolonged antibiotic treatment on cognition in patients with Lyme borreliosis.
Topics: Adult; Anti-Bacterial Agents; Ceftriaxone; Chronic Disease; Clarithromycin; Cognition; Double-Blind Method; Doxycycline; Female; Humans; Hydroxychloroquine; Lyme Disease; Male; Middle Aged; Neuropsychological Tests | 2019 |
Clarithromycin and endoscopic sinus surgery for adults with chronic rhinosinusitis with and without nasal polyps: study protocol for the MACRO randomised controlled trial.
Topics: Administration, Oral; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Comparative Effectiveness Research; Drug Administration Schedule; Endoscopy; Female; Humans; Male; Multicenter Studies as Topic; Nasal Polyps; Nasal Surgical Procedures; Pilot Projects; Randomized Controlled Trials as Topic; Rhinitis; Sinusitis; Time Factors; Treatment Outcome; United Kingdom | 2019 |
High and low doses of clarithromycin treatment are associated with different clinical efficacies and immunomodulatory properties in chronic rhinosinusitis.
Topics: Adult; Anti-Bacterial Agents; Biomarkers; Chronic Disease; Clarithromycin; Dose-Response Relationship, Drug; Female; Humans; Interleukin-5; Interleukin-8; Male; Middle Aged; Quality of Life; Rhinitis; Sinusitis; Surveys and Questionnaires; Treatment Outcome | 2014 |
Efficacy of long-term low-dose macrolide therapy in preventing early recurrence of nasal polyps after endoscopic sinus surgery.
Topics: Adrenal Cortex Hormones; Adult; Chemotherapy, Adjuvant; Chronic Disease; Clarithromycin; Endoscopy; Eosinophil Cationic Protein; Female; Follow-Up Studies; Humans; Male; Mometasone Furoate; Nasal Polyps; Paranasal Sinuses; Pregnadienediols; Recurrence; Rhinitis; Rhinomanometry; Sinusitis; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
[Clinical effect of clarithromycin therapy in patients with chronic rhinosinusitis].
Topics: Adult; Chronic Disease; Clarithromycin; Female; Humans; Male; Middle Aged; Prospective Studies; Sinusitis; Treatment Outcome | 2014 |
Outcome evaluation of clarithromycin, metronidazole and lansoprazole regimens in Helicobacter pylori positive or negative children with resistant otitis media with effusion.
Topics: Amoxicillin; Anti-Bacterial Agents; Antigens, Bacterial; Case-Control Studies; Child; Child, Preschool; Chronic Disease; Clarithromycin; Clavulanic Acid; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Otitis Media with Effusion; Proton Pump Inhibitors; Treatment Outcome | 2015 |
[Months of antibiotic therapy in persistent symptoms of Lyme disease without effect].
Topics: Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Dose-Response Relationship, Drug; Doxycycline; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Long-Term Care; Lyme Disease; Male; Middle Aged; Quality of Life | 2016 |
Effect of eradication of Helicobacter pylori in children with chronic immune thrombocytopenia: a prospective, controlled, multicenter study.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Blood Platelets; Child; Chronic Disease; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Platelet Count; Purpura, Thrombocytopenic, Idiopathic | 2011 |
[Evaluation of the medical and surgical treatment of pediatric chronic rhinosinusitis].
Topics: Adenoidectomy; Adolescent; Child; Chronic Disease; Clarithromycin; Female; Humans; Male; Mometasone Furoate; Pregnadienediols; Sinusitis; Tonsillectomy; Treatment Outcome | 2011 |
Efficacy of combined treatment with S-carboxymethylcysteine (carbocisteine) and clarithromycin in chronic rhinosinusitis patients without nasal polyp or with small nasal polyp.
Topics: Adult; Aged; Anti-Bacterial Agents; Carbocysteine; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nasal Polyps; Prospective Studies; Quality of Life; Rhinitis; Sinusitis; Tomography, X-Ray Computed | 2012 |
[Clinical observation of Clarithromycin combined with nasal steroid treatment for chronic rhinosinusitis].
Topics: Adolescent; Adult; Aged; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nasal Polyps; Rhinitis; Sinusitis; Treatment Outcome; Triamcinolone Acetonide; Young Adult | 2011 |
A randomized trial of standard-dose versus half-dose rabeprazole, clarithromycin, and amoxicillin in the treatment of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Rabeprazole | 2011 |
The effects of transrectal radiofrequency hyperthermia on patients with chronic prostatitis and the changes of MDA, NO, SOD, and Zn levels in pretreatment and posttreatment.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Anti-Bacterial Agents; Body Fluids; Chronic Disease; Clarithromycin; Combined Modality Therapy; Diathermy; Humans; Male; Malondialdehyde; Nitric Oxide; Pelvic Pain; Prostatitis; Quality of Life; Radiofrequency Therapy; Semen; Sulfonamides; Superoxide Dismutase; Tamsulosin; Urination Disorders; Zinc | 2012 |
Prevalence of biofilms and their response to medical treatment in chronic rhinosinusitis without polyps.
Topics: Administration, Oral; Administration, Topical; Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents; Biofilms; Biopsy; Chronic Disease; Clarithromycin; Female; Humans; Male; Microscopy, Electron, Scanning; Middle Aged; Mometasone Furoate; Pregnadienediols; Prevalence; Rhinitis; Sinusitis; Statistics, Nonparametric | 2012 |
[Enterofuril eradication therapy in chronic inflammatory diseases of the upper digestive tract].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Infective Agents; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Humans; Hydroxybenzoates; Male; Metronidazole; Nitrofurans; Pantoprazole; Peptic Ulcer; Treatment Outcome | 2011 |
Optimal duration of macrolide treatment for chronic sinusitis after endoscopic sinus surgery.
Topics: Adult; Aged; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Combined Modality Therapy; Endoscopy; Humans; Middle Aged; Otorhinolaryngologic Surgical Procedures; Paranasal Sinuses; Rhinitis; Sinusitis; Time Factors; Treatment Outcome; Young Adult | 2013 |
Effect of a short course of clarithromycin therapy on sputum production in patients with chronic airway hypersecretion.
Topics: Adult; Aged; Amoxicillin; Animals; Anti-Bacterial Agents; Bronchiectasis; Bronchitis; Cefaclor; Chlorides; Chronic Disease; Clarithromycin; Double-Blind Method; Erythromycin; Female; Humans; Male; Membrane Potentials; Middle Aged; Rabbits; Sputum; Trachea | 2002 |
Cost-effectiveness of gemifloxacin: results from the GLOBE study.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bronchitis; Chronic Disease; Clarithromycin; Cost-Benefit Analysis; Double-Blind Method; Fluoroquinolones; Gemifloxacin; Humans; Naphthyridines; Prospective Studies; Randomized Controlled Trials as Topic; Treatment Outcome | 2002 |
Comparative analysis of azithromycin and clarithromycin efficacy and tolerability in the treatment of chronic prostatitis caused by Chlamydia trachomatis.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Chronic Disease; Clarithromycin; Dose-Response Relationship, Drug; Humans; Male; Maximum Tolerated Dose; Middle Aged; Prospective Studies; Prostatitis; Treatment Outcome | 2002 |
Esberitox N as supportive therapy when providing standard antibiotic treatment in subjects with a severe bacterial infection (acute exacerbation of chronic bronchitis). A multicentric, prospective, double-blind, placebo-controlled study.
Topics: Adjuvants, Immunologic; Adult; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Bronchitis, Chronic; Chronic Disease; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Humans; Lung Diseases, Obstructive; Pilot Projects; Plant Extracts; Roxithromycin; Time Factors | 2002 |
[Combined therapy for patients with chronic paranasal sinusitis using a macrolide antibiotic and YAMIK catheter].
Topics: Adolescent; Adult; Aged; Anti-Allergic Agents; Anti-Bacterial Agents; Catheterization; Child; Chronic Disease; Clarithromycin; Humans; Middle Aged; Rhinitis, Allergic, Perennial; Sinusitis; Treatment Outcome | 2003 |
[Combined drug therapy for patients with intractable paranasal sinusitis complicating allergic rhinitis].
Topics: Anti-Allergic Agents; Anti-Bacterial Agents; Arylsulfonates; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Female; Humans; Male; Rhinitis, Allergic, Perennial; Roxithromycin; Sinusitis; Sulfonium Compounds; Treatment Outcome | 2003 |
Effect of Helicobacter pylori eradication on platelet recovery in patients with chronic idiopathic thrombocytopenic purpura.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Infective Agents; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Male; Omeprazole; Platelet Count; Purpura, Thrombocytopenic, Idiopathic | 2004 |
Effect of high-dose aspirin on Helicobacter pylori eradication.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aspirin; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Pilot Projects | 2005 |
[Oral clarithromycin as a treatment option in chronic post-operative endophthalmitis].
Topics: Administration, Oral; Aged; Aged, 80 and over; Cataract Extraction; Chronic Disease; Clarithromycin; Combined Modality Therapy; Endophthalmitis; Female; Gram-Positive Bacterial Infections; Humans; Lens Capsule, Crystalline; Lens Implantation, Intraocular; Male; Middle Aged; Phacoemulsification; Propionibacterium acnes; Prospective Studies; Prosthesis-Related Infections; Remission Induction; Staphylococcal Infections; Staphylococcus epidermidis; Surgical Wound Infection; Therapeutic Irrigation; Treatment Outcome; Vitrectomy | 2005 |
Role of chronic infection and inflammation in the gastrointestinal tract in the etiology and pathogenesis of idiopathic parkinsonism. Part 2: response of facets of clinical idiopathic parkinsonism to Helicobacter pylori eradication. A randomized, double-b
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chronic Disease; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Inflammation; Omeprazole; Parkinson Disease; Treatment Outcome | 2005 |
Five-day telithromycin once daily is as effective as 10-day clarithromycin twice daily for the treatment of acute exacerbations of chronic bronchitis and is associated with reduced health-care resource utilization.
Topics: Acute Disease; Adult; Aged; Bronchitis; Chronic Disease; Clarithromycin; Disease Progression; Double-Blind Method; Drug Administration Schedule; Female; Forced Expiratory Volume; Health Care Rationing; Humans; Ketolides; Male; Middle Aged; Single-Blind Method; Smoking; Vital Capacity | 2005 |
[Chronic sinusitis therapy with antibiotics (axetyl cefuroxym, clarithromycin) and steroid (prednisone)].
Topics: Anti-Infective Agents; Cefuroxime; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Female; Humans; Male; Prednisone; Sinusitis; Treatment Outcome | 2005 |
Eradication of Helicobacter pylori infection reverses E-cadherin promoter hypermethylation.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Cadherins; Chronic Disease; Clarithromycin; DNA Methylation; Drug Therapy, Combination; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Immunohistochemistry; Intestines; Male; Metaplasia; Middle Aged; Omeprazole; Promoter Regions, Genetic; Prospective Studies | 2006 |
H. pylori infection in childhood chronic immune thrombocytopenic purpura.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Child, Preschool; Chronic Disease; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Male; Netherlands; Omeprazole; Platelet Count; Prevalence; Prospective Studies; Purpura, Thrombocytopenic, Idiopathic; Remission Induction | 2007 |
Evidence for the role of gastric mucosa at the secretion of soluble triggering receptor expressed on myeloid cells (strem-1) in peptic ulcer disease.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chronic Disease; Clarithromycin; Drug Administration Schedule; Duodenal Ulcer; Endoscopy, Gastrointestinal; Female; Gastric Juice; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lipopolysaccharides; Male; Membrane Glycoproteins; Middle Aged; Omeprazole; Receptors, Immunologic; Severity of Illness Index; Stomach Ulcer; Tissue Culture Techniques; Triggering Receptor Expressed on Myeloid Cells-1; Tumor Necrosis Factor-alpha | 2007 |
Eradication of Helicobacter pylori infection equally improves chronic urticaria with positive and negative autologous serum skin test.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Autoantibodies; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Skin Tests; Treatment Outcome; Urticaria | 2007 |
The role of Helicobacter pylori in children with chronic idiopathic thrombocytopenic purpura.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Child; Child, Preschool; Chronic Disease; Clarithromycin; Colony Count, Microbial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Male; Platelet Count; Prospective Studies; Proton Pump Inhibitors; Purpura, Thrombocytopenic, Idiopathic; Recovery of Function; Recurrence | 2008 |
Effect of clarithromycin on sputum production and its rheological properties in chronic respiratory tract infections.
Topics: Adult; Aged; Anti-Bacterial Agents; Bronchiolitis; Bronchitis; Chronic Disease; Clarithromycin; Colony Count, Microbial; Double-Blind Method; Elasticity; Female; Humans; Male; Middle Aged; Respiratory Tract Infections; Rheology; Sputum; Viscosity | 1995 |
[Therapeutic efficacy of macrolide in pulmonary nontuberculous mycobacteriosis].
Topics: Aged; Aged, 80 and over; Animals; Chronic Disease; Clarithromycin; Female; Humans; Male; Mice; Mice, Inbred BALB C; Middle Aged; Mycobacterium avium-intracellulare Infection; Tuberculosis, Pulmonary | 1994 |
Immunostimulation by clarithromycin in healthy volunteers and chronic bronchitis patients.
Topics: Adjuvants, Immunologic; Adult; Bronchitis; Chemotaxis, Leukocyte; Chronic Disease; Clarithromycin; Female; Humans; Immunity, Cellular; Killer Cells, Natural; Male; Middle Aged; Phagocytosis | 1993 |
A comparison of 5 days of dirithromycin and 7 days of clarithromycin in acute bacterial exacerbation of chronic bronchitis.
Topics: Acute Disease; Aged; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Chronic Disease; Clarithromycin; Erythromycin; Female; Humans; Macrolides; Male; Middle Aged; Patient Compliance; Single-Blind Method | 1995 |
Omeprazole-based dual and triple regimens for Helicobacter pylori eradication in children.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Biopsy; Child; Chronic Disease; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Gastric Acid; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Penicillins; Peptic Ulcer; Pyloric Antrum; Treatment Outcome | 1997 |
[Omeprazole, clarithromycin and amoxicillin therapy for Helicobacter pylori infection].
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Penicillins | 1996 |
Efficacy of oral ciprofloxacin vs. clarithromycin for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Bronchitis; Chronic Disease; Ciprofloxacin; Clarithromycin; Consumer Product Safety; Double-Blind Method; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Time Factors; Treatment Outcome | 1998 |
Chronic urticaria and Helicobacter pylori.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Blood Donors; Breath Tests; Carbon Isotopes; Chronic Disease; Clarithromycin; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Male; Metronidazole; Middle Aged; Omeprazole; Prevalence; Remission Induction; Stomach; Urea; Urticaria | 1998 |
Treatment of Helicobacter pylori and Chlamydia pneumoniae infections decreases fibrinogen plasma level in patients with ischemic heart disease.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Chlamydia Infections; Chlamydophila pneumoniae; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Female; Fibrinogen; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Ischemia; Omeprazole; Risk Factors; Tinidazole | 1999 |
Treating acute bacterial exacerbations of chronic bronchitis in patients unresponsive to previous therapy: sparfloxacin versus clarithromycin.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Antitubercular Agents; Bronchitis; Chronic Disease; Clarithromycin; Double-Blind Method; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged | 1999 |
Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Quality of Life; Treatment Outcome | 1999 |
[Reinfection with Helicobacter pylori in patients with duodenal ulcer after successful eradication].
Topics: Adult; Amoxicillin; Bismuth; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Duodenoscopy; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Recurrence; Wound Healing | 1999 |
Comparison of spiramycin and clarithromycin for community-acquired lower respiratory tract infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bronchitis; Chronic Disease; Clarithromycin; Community-Acquired Infections; Female; Humans; Male; Middle Aged; Pneumonia; Spiramycin | 1999 |
Comparison of the abilities of grepafloxacin and clarithromycin to eradicate potential bacterial pathogens from the sputa of patients with chronic bronchitis: influence of pharmacokinetic and pharmacodynamic variables.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Bronchitis; Chronic Disease; Clarithromycin; Female; Fluoroquinolones; Haemophilus; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Models, Biological; Piperazines; Serum Bactericidal Test; Sputum | 2000 |
Phase III, randomized, double-blind study of clarithromycin extended-release and immediate-release formulations in the treatment of patients with acute exacerbation of chronic bronchitis.
Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; Bronchitis; Chronic Disease; Clarithromycin; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Middle Aged; Patient Compliance | 2000 |
[Effect and action mechanism of short-term administration of clarithromycin for airway hypersecretion].
Topics: Action Potentials; Aged; Animals; Anti-Bacterial Agents; Bronchiectasis; Bronchitis; Chronic Disease; Clarithromycin; Depression, Chemical; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Rabbits; Respiratory Mucosa; Sputum | 2001 |
Helicobacter pylori and iron deficiency anaemia in children.
Topics: Adolescent; Amoxicillin; Anemia, Iron-Deficiency; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Child; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Hemoglobins; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Proton Pump Inhibitors; Urea | 2001 |
Therapeutic effects of antibacterial treatment for intractable skin diseases in Helicobacter pylori-positive Japanese patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Child; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Lansoprazole; Male; Middle Aged; Omeprazole; Skin Diseases; Treatment Outcome | 2002 |
A comparison of gemifloxacin and clarithromycin in acute exacerbations of chronic bronchitis and long-term clinical outcomes.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bronchitis; Chronic Disease; Clarithromycin; Double-Blind Method; Female; Fluoroquinolones; Gemifloxacin; Haemophilus influenzae; Humans; Male; Middle Aged; Naphthyridines; Recurrence; Sputum; Treatment Outcome | 2002 |
Comparative safety and efficacy of clarithromycin and ampicillin in the treatment of out-patients with acute bacterial exacerbation of chronic bronchitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Ampicillin; Bacterial Infections; Bronchitis; Chi-Square Distribution; Chronic Disease; Clarithromycin; Erythromycin; Female; Humans; Male; Middle Aged; Recurrence; Treatment Outcome | 1992 |
A comparison of clarithromycin with ampicillin in the treatment of outpatients with acute bacterial exacerbation of chronic bronchitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Ampicillin; Bacterial Infections; Bronchitis; Chronic Disease; Clarithromycin; Double-Blind Method; Erythromycin; Female; Humans; Male; Middle Aged | 1991 |
Comparative study of clarithromycin and ampicillin in the treatment of patients with acute bacterial exacerbations of chronic bronchitis.
Topics: Adult; Aged; Aged, 80 and over; Ampicillin; Bacterial Infections; Bronchitis; Chronic Disease; Clarithromycin; Double-Blind Method; Erythromycin; Female; Humans; Male; Middle Aged; Remission Induction; Sputum | 1991 |
95 other study(ies) available for clarithromycin and Chronic Disease
| Article | Year |
|---|---|
Overexpression of hypoxia-inducible factor 1α is associated with neutrophilic inflammation in chronic rhinosinusitis with nasal polyps.
Topics: Adult; Anti-Bacterial Agents; Blotting, Western; Case-Control Studies; Chronic Disease; Clarithromycin; Cytokines; Dexamethasone; Drug Resistance; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Inflammation; Male; Middle Aged; Nasal Polyps; Neutrophils; Reverse Transcriptase Polymerase Chain Reaction; Rhinitis; RNA, Messenger; Sinusitis | 2020 |
The Relationship between the Sydney Classification and the First-Line Treatment Efficacy in Helicobacter-Associated Gastritis.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chronic Disease; Clarithromycin; Clinical Protocols; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metaplasia; Middle Aged; Pantoprazole; Severity of Illness Index | 2020 |
Clarithromycin inhibits TNF-α-induced MUC5AC mucin gene expression via the MKP-1-p38MAPK-dependent pathway.
Topics: Anti-Bacterial Agents; Bronchi; Bronchitis, Chronic; Cell Line; Chronic Disease; Clarithromycin; Dual Specificity Phosphatase 1; Epithelial Cells; Gene Expression Regulation; Humans; Mucin 5AC; p38 Mitogen-Activated Protein Kinases; Signal Transduction; Sinusitis; Tumor Necrosis Factor-alpha | 2017 |
Disseminated Mycobacterium marinum skin infection due to chronic lymphedema in an immunocompetent patient.
Topics: Biopsy; Chronic Disease; Clarithromycin; Dermis; Diagnosis, Differential; Doxycycline; Drug Therapy, Combination; Epidermis; Female; Humans; Immunocompetence; Leg Dermatoses; Lymphedema; Middle Aged; Mycobacterium Infections, Nontuberculous; Rifampin | 2018 |
Helicobacter pylori in esplenectomized patients with immune primary trombocytopenia
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Platelet Count; Proton Pump Inhibitors; Purpura, Thrombocytopenic, Idiopathic; Splenectomy; Treatment Outcome | 2017 |
Clarithromycin resistance and female gender affect Helicobacter pylori eradication failure in chronic gastritis.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gastritis; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Pantoprazole; Pharmacogenomic Variants; Proton Pump Inhibitors; Risk Assessment; Risk Factors; Sex Factors; Treatment Failure | 2019 |
Chronic otitis media caused by Mycobacterium abscessus spp. massiliense treated with tigecycline in a 10-year-old child.
Topics: Amikacin; Anti-Bacterial Agents; Child; Chronic Disease; Clarithromycin; Humans; Male; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Otitis Media; Tigecycline; Tokyo | 2018 |
The development of diffuse panbronchiolitis during the treatment with long-term, low-dose clarithromycin for chronic sinusitis.
Topics: Adult; Anti-Bacterial Agents; Bronchiolitis; Chronic Disease; Clarithromycin; Haemophilus Infections; Humans; Male; Sinusitis | 2019 |
Sinobronchial syndrome treated as intractable asthma.
Topics: Anti-Asthmatic Agents; Anti-Bacterial Agents; Asthma; Bronchitis; Child; Chronic Disease; Clarithromycin; Diagnosis, Differential; Humans; Male; Respiratory Function Tests; Sinusitis; Tomography, X-Ray Computed | 2018 |
Bacterial profile and antimicrobial susceptibility patterns in chronic suppurative otitis media at the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Chronic Disease; Ciprofloxacin; Clarithromycin; Ethiopia; Hospitals, Special; Hospitals, University; Humans; Microbial Sensitivity Tests; Norfloxacin; Otitis Media, Suppurative; Proteus mirabilis; Staphylococcus aureus | 2019 |
Pharmacotherapy of Chronic Rhinosinusitis with a Focus on Clarithromycin: An Expert Opinion.
Topics: Chronic Disease; Clarithromycin; Expert Testimony; Humans; Quality of Life; Rhinitis | 2018 |
Prevalence of clarithromycin-resistant Helicobacter pylori in patients with chronic tonsillitis by allele-specific Scorpion real-time polymerase chain reaction assay.
Topics: Adolescent; Adult; Alleles; Anti-Bacterial Agents; Biopsy; Child; Child, Preschool; Chronic Disease; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Iran; Prevalence; Real-Time Polymerase Chain Reaction; Tonsillitis; Young Adult | 2013 |
Comparison of antimicrobial activity of zinc chloride and bismuth subsalicylate against clinical isolates of Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Bismuth; Chlorides; Chronic Disease; Clarithromycin; Drug Resistance, Bacterial; Dyspepsia; Female; Gastric Juice; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Male; Microbial Sensitivity Tests; Middle Aged; Organometallic Compounds; Peptic Ulcer; Salicylates; Zinc Compounds | 2014 |
The efficacy of clarithromycin in patients with severe nasal polyposis.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Endoscopy; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nasal Obstruction; Nasal Polyps; Prospective Studies; Severity of Illness Index; Surveys and Questionnaires; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2013 |
Gastritis due to Helicobacter pylori, an unusual cause of chronic diarrhoea in HIV infected patients.
Topics: Aged; Amoxicillin; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Breath Tests; Chronic Disease; Clarithromycin; Diarrhea; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; HIV Infections; HIV-1; Humans; Male; Middle Aged; Omeprazole | 2014 |
[Rationale for improved treatment of ulcerative disease complicated by chronic pyelonephritis].
Topics: Aged; Amoxicillin; Anti-Ulcer Agents; Chronic Disease; Clarithromycin; Diet; Female; Helicobacter Infections; Helicobacter pylori; Humans; Inflammation; Kidney; Male; Middle Aged; Pyelonephritis; Rabeprazole; Risk Factors; Treatment Outcome; Ulcer | 2013 |
[The expression of VEGF and the regulation of clarithromycin on it in chronic rhinosinusitis with nasal polys].
Topics: Adult; Chronic Disease; Clarithromycin; Female; Humans; Male; Nasal Mucosa; Nasal Polyps; Rhinitis; Sinusitis; Vascular Endothelial Growth Factor A; Young Adult | 2014 |
Effect of antibiotic use on bacterial flora of tonsil core in patients with recurrent tonsillitis.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria; Chemoprevention; Child; Chronic Disease; Clarithromycin; Female; Humans; Male; Palatine Tonsil; Prevalence; Prospective Studies; Pseudomonas aeruginosa; Recurrence; Tonsillectomy; Tonsillitis; Turkey; Viridans Streptococci | 2015 |
Changes in the first line Helicobacter pylori eradication rates using the triple therapy-a multicenter study in the Tokyo metropolitan area (Tokyo Helicobacter pylori study group).
Topics: Amoxicillin; Chronic Disease; Clarithromycin; Disease Eradication; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Time Factors; Tokyo | 2014 |
Treatment and prevention of paronychia using a new combination of topicals: report of 30 cases.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antifungal Agents; Chronic Disease; Clarithromycin; Dermatologic Agents; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluconazole; Follow-Up Studies; Humans; Imidazoles; Male; Middle Aged; Nail Diseases; Occupational Diseases; Paronychia; Polymers; Pyridones; Young Adult | 2015 |
Clarithromycin and dexamethasone show similar anti-inflammatory effects on distinct phenotypic chronic rhinosinusitis: an explant model study.
Topics: Adult; Anti-Inflammatory Agents; Biomarkers; Cell Survival; Chronic Disease; Clarithromycin; Cytokines; Dendritic Cells; Dexamethasone; Dose-Response Relationship, Drug; Epithelial Cells; Female; Gene Expression Regulation; Humans; Inflammation Mediators; Male; Middle Aged; Mifepristone; Models, Biological; Phenotype; Pilot Projects; Receptors, Pattern Recognition; Rhinitis; Sinusitis; T-Lymphocytes, Helper-Inducer | 2015 |
Mycobacterium fortuitum thoracic empyema: A case report and review of the literature.
Topics: Amikacin; Anti-Bacterial Agents; Chronic Disease; Cilastatin; Cilastatin, Imipenem Drug Combination; Clarithromycin; Drug Combinations; Drug Therapy, Combination; Empyema, Pleural; Humans; Hypercapnia; Imipenem; Male; Middle Aged; Mycobacterium fortuitum; Noninvasive Ventilation; Sulfamethoxazole | 2015 |
Effects of Helicobacter pylori Eradication in Chronic Spontaneous Urticaria: Results from a Retrospective Cohort Study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Chi-Square Distribution; Chronic Disease; Clarithromycin; Cohort Studies; Comorbidity; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Histamine Antagonists; Humans; Male; Middle Aged; Pantoprazole; Retrospective Studies; Risk Assessment; Severity of Illness Index; Treatment Outcome; Urticaria | 2015 |
The value of a feasibility study into long-term macrolide therapy in chronic rhinosinusitis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents; Chronic Disease; Clarithromycin; Drug Administration Schedule; Feasibility Studies; Female; Humans; Male; Medication Adherence; Middle Aged; Mometasone Furoate; Patient Selection; Prospective Studies; Rhinitis; Sinusitis; Therapeutic Irrigation; United Kingdom; Young Adult | 2017 |
Clarithromycin resistance and prevalence of Helicobacter pylori virulent genotypes in patients from Southern México with chronic gastritis.
Topics: Adult; Aged; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Proteins; Chronic Disease; Clarithromycin; Cross-Sectional Studies; Drug Resistance, Bacterial; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Mexico; Microbial Sensitivity Tests; Middle Aged; Mutation; RNA, Ribosomal, 23S; Virulence | 2016 |
Effects of long-term clarithromycin treatment on lavage-fluid markers of inflammation in chronic rhinosinusitis.
Topics: Adult; Anti-Bacterial Agents; Australia; Biomarkers; Bronchoalveolar Lavage Fluid; Chronic Disease; Clarithromycin; Cytokines; Female; Histamine; Histamine Agonists; Humans; Inflammation; Male; Middle Aged; Rhinitis; Sinusitis; Time | 2009 |
A study of poor responders for long-term, low-dose macrolide administration for chronic sinusitis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Cohort Studies; Drug Administration Schedule; Drug Resistance; Female; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Roxithromycin; Sinusitis; Tomography, X-Ray Computed; Treatment Failure; Young Adult | 2009 |
[Effect of eradication therapy on nitrogen oxide activity in the gastric juice of patients with chronic gastritis and ulcer disease].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastric Juice; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Nitric Oxide; Omeprazole; Proton Pump Inhibitors | 2009 |
A case of Good's syndrome: a rare acquired immunodeficiency associated with thymoma.
Topics: Aged; Anti-Bacterial Agents; Biopsy; Chronic Disease; Clarithromycin; Common Variable Immunodeficiency; Humans; Male; Neoplasms, Glandular and Epithelial; Pneumonia; Recurrence; Sinusitis; Thymectomy; Thymoma; Thymus Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Evaluation of long-term clarithromycin treatment in adult Chinese Patients with chronic rhinosinusitis without nasal polyps.
Topics: Adult; Anti-Bacterial Agents; China; Chronic Disease; Clarithromycin; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Nasal Polyps; Prevalence; Rhinitis; Sinusitis; Time Factors; Treatment Outcome | 2011 |
Helicobacter pylori associated with chronic urticaria.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Middle Aged; Omeprazole; Treatment Outcome; Urticaria | 2011 |
[Primary antibiotic resistance of Helicobacter pylori strains and eradication rate according to gastroduodenal disease in Korea].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Republic of Korea; Stomach Neoplasms | 2011 |
[Long-term clarithromycin therapy in patients with chronic polypous rhinosinusitis].
Topics: Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Humans; Quality of Life; Rhinitis; Sinusitis | 2011 |
[Experience with treatment of chronic polypoid rhinosinusitis using low doses of clarithromycin in the postoperative period].
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Aged; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Maxillary Sinusitis; Middle Aged; Nasal Polyps; Postoperative Period; Rhinitis; Secondary Prevention; Treatment Outcome | 2012 |
A case of difficult-to-treat eosinophilic asthma controlled with clarithromycin.
Topics: Anti-Bacterial Agents; Asthma; Chronic Disease; Clarithromycin; Eosinophilia; Glucocorticoids; Humans; Immunoglobulins; Male; Middle Aged; Prednisone; Sinusitis; Sputum; Treatment Outcome | 2012 |
Is there still a role for empiric first-line triple therapy using proton pump inhibitor, amoxicillin and clarithromycin for Helicobacter pylori infection in Singapore? Results of a time trend analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Middle Aged; Peptic Ulcer; Proton Pump Inhibitors; Retrospective Studies; Singapore; Treatment Outcome; Young Adult | 2013 |
First report of lung transplantation in a patient with active pulmonary Mycobacterium simiae infection.
Topics: Anti-Bacterial Agents; Aza Compounds; Bronchiectasis; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Lung Transplantation; Middle Aged; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Quinolines; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2013 |
Improvement of long-standing iron-deficiency anemia in adults after eradication of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anemia, Iron-Deficiency; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Female; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Hematologic Tests; Humans; Lansoprazole; Omeprazole; Penicillins; Treatment Outcome | 2002 |
Chronic urticaria induced by eradication therapy of Helicobacter pylori: a case report.
Topics: Amoxicillin; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Urticaria | 2002 |
Effect of new macrolides on the expression of adhesion molecules on neutrophils in chronic sinusitis.
Topics: Adolescent; Adult; Aged; Chronic Disease; Clarithromycin; Down-Regulation; Female; Humans; Interleukin-8; L-Selectin; Macrophage-1 Antigen; Male; Middle Aged; Neutrophils; Roxithromycin; Sinusitis; Up-Regulation | 2002 |
Clarithromycin and prednisolone inhibit cytokine production in chronic rhinosinusitis.
Topics: Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents; Chronic Disease; Clarithromycin; Culture Techniques; Cytokines; Enzyme-Linked Immunosorbent Assay; Female; Glucocorticoids; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interleukin-5; Interleukin-8; Male; Middle Aged; Nasal Mucosa; Prednisolone; Rhinitis; Sinusitis | 2002 |
[Anti-microbial sensitivities of bacteria isolated from patients with chronic lower respiratory tract infection under long-term macrolide therapy].
Topics: Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Haemophilus influenzae; Humans; Pseudomonas aeruginosa; Respiratory Tract Infections; Streptococcus pneumoniae; Time Factors | 2001 |
[Epidemiological study on patients with pneumococcal respiratory tract infection in a Japanese health facility during the past year].
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Chronic Disease; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Lactams; Male; Middle Aged; Ofloxacin; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae; Time Factors | 2001 |
Effect of clarithromycin on nuclear factor-kappa B and transforming growth factor-beta in chronic rhinosinusitis.
Topics: Adult; Anti-Inflammatory Agents; Biopsy; Cells, Cultured; Chronic Disease; Clarithromycin; Female; Humans; Immunohistochemistry; Male; Middle Aged; Nasal Mucosa; NF-kappa B; Paranasal Sinus Diseases; Sinusitis; Transforming Growth Factor beta | 2004 |
Is it spontaneous resolution or macrolide efficacy?
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Chronic Disease; Clarithromycin; Female; Gram-Negative Bacterial Infections; Humans; Infant; Macrolides; Male; Microbial Sensitivity Tests; Moraxella catarrhalis; Nasopharynx; Otitis Media with Effusion; Pneumococcal Infections; Rhinitis; Sinusitis; Streptococcus pneumoniae | 2004 |
Bronchus-associated lymphoid tissue lymphoma arising in a patient with bronchiectasis and chronic Mycobacterium avium infection.
Topics: Aged; Anti-Infective Agents; Bronchial Neoplasms; Bronchiectasis; Chronic Disease; Ciprofloxacin; Clarithromycin; Disease-Free Survival; Female; Humans; Lymphoma, B-Cell; Mycobacterium avium; Tuberculosis | 2004 |
Recurrence of Helicobacter pylori infection 1 year after successful treatment: prospective cohort study in the Republic of Yemen.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prevalence; Prospective Studies; Recurrence; Yemen | 2004 |
[Helicobacter pylori infection in patients with chronic hives and asthma].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antibodies, Bacterial; Asthma; Chronic Disease; Clarithromycin; Enzyme Inhibitors; Feces; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin E; Male; Middle Aged; Omeprazole; Treatment Outcome; Urticaria | 2005 |
[Analysis of the mechanism of suppression on MUC5AC by macrolides--an analysis by using a chronic airway infection model].
Topics: Animals; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Disease Models, Animal; Male; Mice; Mucin 5AC; Mucins; Respiratory Tract Infections | 2004 |
Altered expression of Skp2, c-Myc and p27 proteins but not mRNA after H. pylori eradication in chronic gastritis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chronic Disease; Clarithromycin; Cyclin-Dependent Kinase Inhibitor p27; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Immunohistochemistry; Interleukin-8; Lansoprazole; Male; Middle Aged; Omeprazole; Proteins; Proto-Oncogene Proteins c-myc; Proton Pump Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; S-Phase Kinase-Associated Proteins | 2006 |
[A case of Mycobacterium intracellulare infection with chronic empyema].
Topics: Aged, 80 and over; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Empyema; Ethambutol; Humans; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Radiography, Thoracic; Rifampin; Streptomycin; Tomography, X-Ray Computed | 2006 |
Telithromycin inhibits the number of viable bacteria but not lymphocyte accumulation in a murine model of chronic respiratory infection.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Chronic Disease; Clarithromycin; Disease Models, Animal; Ketolides; Lung; Lymphocytes; Male; Mice; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections | 2007 |
Patterns of Helicobacter pylori isolate resistance to fluoroquinolones, amoxicillin, clarithromycin and metronidazoles.
Topics: Amoxicillin; Anti-Bacterial Agents; Biopsy; Chronic Disease; Clarithromycin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Dyspepsia; Fluoroquinolones; Gastritis; Helicobacter pylori; Humans; Metronidazole; Pyloric Antrum | 2006 |
Duodenal gastric metaplasia and Helicobacter pylori infection in patients with diffuse nodular duodenitis.
Topics: Adult; Aged; Case-Control Studies; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Duodenitis; Duodenoscopy; Duodenum; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metaplasia; Metronidazole; Middle Aged; Omeprazole; Severity of Illness Index | 2007 |
Clearance of chronic psoriasis after eradication therapy for Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Female; Helicobacter Infections; Humans; Middle Aged; Psoriasis | 2008 |
Helicobacter pylori infection in children with chronic idiopathic thrombocytopenic purpura.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Child; Child, Preschool; Chronic Disease; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Platelet Count; Prospective Studies; Proton Pump Inhibitors; Purpura, Thrombocytopenic, Idiopathic | 2008 |
Effect of eradication of Helicobacter pylori on the histology and cellular phenotype of gastric intestinal metaplasia.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Infective Agents; Antibodies; Biopsy; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metaplasia; Middle Aged; Phenotype; Prospective Studies; Stomach; Stomach Neoplasms; Tropomyosin; Tumor Suppressor Protein p53 | 2008 |
Clarithromycin attenuates acute and chronic rejection via matrix metalloproteinase suppression in murine cardiac transplantation.
Topics: Acute Disease; Animals; Chronic Disease; Clarithromycin; Gene Expression; Graft Rejection; Heart Transplantation; Leukocytes, Mononuclear; Male; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Myocytes, Smooth Muscle; Protein Synthesis Inhibitors | 2008 |
[Recent advances in macrolide antibiotics: focused on clarithromycin. Discussion].
Topics: Chronic Disease; Clarithromycin; Humans; Respiratory Tract Infections | 1994 |
Bacterial biofilm in chronic airway infection.
Topics: Animals; Anti-Bacterial Agents; Bacterial Adhesion; Bronchiectasis; Bronchoalveolar Lavage Fluid; Chemotaxis; Chronic Disease; Clarithromycin; Humans; In Vitro Techniques; Lung; Male; Mice; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections | 1994 |
Clarithromycin-induced leukocytoclastic vasculitis.
Topics: Adrenal Cortex Hormones; Aged; Bronchitis; Chronic Disease; Clarithromycin; Humans; Male; Vasculitis, Leukocytoclastic, Cutaneous | 1993 |
Levofloxacin in patients with severe respiratory tract infection.
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Asthma; Bronchitis; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Pseudomonas aeruginosa; Respiratory Tract Infections | 1995 |
[Effect of clarithromycin on symptoms and mucociliary transport in patients with sino-bronchial syndrome].
Topics: Adult; Aged; Anti-Bacterial Agents; Bronchial Diseases; Chronic Disease; Clarithromycin; Female; Humans; Male; Middle Aged; Mucociliary Clearance; Sinusitis; Syndrome | 1995 |
Successful treatment of chronic Mycobacterium abscessus otitis media with clarithromycin.
Topics: Anti-Bacterial Agents; Child, Preschool; Chronic Disease; Clarithromycin; Down Syndrome; Humans; Male; Mycobacterium Infections; Otitis Media | 1996 |
Effect of clarithromycin on lymphocytes in chronic respiratory Pseudomonas aeruginosa infection.
Topics: Animals; Anti-Bacterial Agents; Bronchiolitis; CD4-CD8 Ratio; Chronic Disease; Clarithromycin; Lung; Lymphocytes; Mice; Pseudomonas aeruginosa; Pseudomonas Infections | 1997 |
Relation of lactoferrin levels in gastric mucosa with Helicobacter pylori infection and with the degree of gastric inflammation.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Ammonia; Anti-Bacterial Agents; Anti-Ulcer Agents; Biomarkers; Biopsy; Chronic Disease; Clarithromycin; Duodenal Ulcer; Female; Follow-Up Studies; Gastric Juice; Gastric Mucosa; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Interleukin-8; Lactoferrin; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Pyloric Antrum | 1997 |
[One-week treatment with omeprazole, clarithromycin and amoxicillin: high efficacy in the eradication of Helicobacter pylori and cicatrization of duodenal ulcer].
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Multivariate Analysis; Omeprazole; Penicillins; Prospective Studies; Time Factors; Wound Healing | 1997 |
[Helicobacter pylori infection and recurrent abdominal pain in children. A proved relationship?].
Topics: Abdominal Pain; Adolescent; Adult; Age Factors; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Child; Chronic Disease; Clarithromycin; Clinical Trials as Topic; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Penicillins; Recurrence; Risk Factors; Stomach Ulcer | 1998 |
[Efficacy of clarithromycin on chronic paranasal sinusitis--a comparison between children and adult].
Topics: Anti-Bacterial Agents; Child; Chronic Disease; Clarithromycin; Female; Humans; Male; Middle Aged; Roxithromycin; Sinusitis | 1997 |
[Immunohistochemical study of the paranasal sinus mucosa of patients being treated with macrolide antibiotics--effects of antigen-presenting cells on the expression of a costimulator].
Topics: Anti-Bacterial Agents; Antigen-Presenting Cells; B7-1 Antigen; Chronic Disease; Clarithromycin; Humans; Immunohistochemistry; Mucous Membrane; Roxithromycin; Sinusitis | 1998 |
[Changes in adhesion molecule expressions in neutrophils caused by new macrolide administration].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Female; Humans; L-Selectin; Macrophage-1 Antigen; Male; Middle Aged; Neutrophils; Sinusitis | 1998 |
[Test to set dosages for long-term administration of clarithromycin to treat chronic paranasal sinusitis].
Topics: Adult; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Humans; Long-Term Care; Sinusitis | 1998 |
[Mucous pathology and macrolide treatment of paranasal sinusitis in children].
Topics: Adolescent; Anti-Bacterial Agents; Child; Chronic Disease; Clarithromycin; Erythromycin; Humans; Mucous Membrane; Sinusitis | 1998 |
[Neutrophil count and IL-8 level of nasal secretion of patients with chronic paranasal sinusitis and the effects of macrolide antibiotics].
Topics: Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Female; Humans; Interleukin-8; Leukocyte Count; Male; Middle Aged; Nasal Mucosa; Neutrophils; Sinusitis | 1998 |
Clarithromycin as a single-modality treatment in mycobacterial avium-intracellular infections.
Topics: Anti-Bacterial Agents; Child; Chronic Disease; Clarithromycin; Female; Humans; Infant; Lymphatic Diseases; Mycobacterium avium-intracellulare Infection; Neck | 1999 |
Chronic pneumonia caused by Mycobacterium thermoresistibile in a cat.
Topics: Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Chronic Disease; Clarithromycin; Doxycycline; Female; Mycobacterium; Pneumonia; Rifampin | 1999 |
Primary and combined resistance to four antimicrobial agents in Helicobacter pylori in Sofia, Bulgaria.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bulgaria; Child; Child, Preschool; Chronic Disease; Ciprofloxacin; Clarithromycin; Drug Combinations; Drug Resistance, Microbial; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Peptic Ulcer; Stomach; Tetracycline | 2000 |
Effects of clarithromycin on rheological properties of nasal mucus in patients with chronic sinusitis.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Elasticity; Female; Humans; Male; Middle Aged; Nasal Mucosa; Retrospective Studies; Rheology; Sinusitis; Treatment Outcome; Viscosity | 2000 |
Effects of macrolides on interleukin-8 secretion from human nasal epithelial cells.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cells, Cultured; Child; Chronic Disease; Clarithromycin; Drug Administration Schedule; Epithelium; Erythromycin; Humans; Interleukin-1; Interleukin-8; Middle Aged; Nasal Mucosa; Neutrophils; Nose; Sinusitis | 2000 |
Combination therapy for chronic Pseudomonas aeruginosa respiratory infection associated with biofilm formation.
Topics: Animals; Biofilms; Chronic Disease; Clarithromycin; Disease Models, Animal; Drug Therapy, Combination; Intubation; Levofloxacin; Male; Mice; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections | 2000 |
Eradication of mycobacterium abscessus in a chronically infected patient with cystic fibrosis.
Topics: Administration, Inhalation; Administration, Oral; Adult; Amikacin; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Cystic Fibrosis; Drug Therapy, Combination; Female; Humans; Lung Abscess; Mycobacterium; Mycobacterium Infections; Recurrence | 2000 |
[Chronic paronychia and synovialitis of extensor tendons due to Mycobacterium marinum. Is diagnosis or treatment the problem?].
Topics: Adult; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Biopsy; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Elbow Joint; Ethambutol; Female; Humans; Mycobacterium Infections, Nontuberculous; Mycobacterium marinum; Paronychia; Rifabutin; Synovectomy; Synovial Membrane; Synovitis | 2000 |
[Influence of macrolide therapy on microorganism of chronic respiratory tract infections].
Topics: Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Erythromycin; Haemophilus influenzae; Humans; Klebsiella pneumoniae; Respiratory Tract Infections; Roxithromycin; Streptococcus pneumoniae | 2000 |
Pharmacokinetics of clarithromycin in the prostate: implications for the treatment of chronic abacterial prostatitis.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Humans; Male; Prostate; Prostatectomy; Prostatic Hyperplasia; Prostatitis; Time Factors; Tissue Distribution | 2001 |
[Changes in bacterial flora of nasopharynx in children treated with long-term administration of macrolides].
Topics: Acute Disease; Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Chronic Disease; Clarithromycin; Drug Resistance, Microbial; Humans; Nasopharynx; Otitis Media with Effusion; Penicillin Resistance; Sinusitis; Streptococcus pneumoniae | 2001 |
[Changes in bacterial flora after long-term administration of clarithromycin].
Topics: Bacteria; Chronic Disease; Clarithromycin; Fungi; Humans; Larynx; Nasal Cavity; Sinusitis; Time Factors | 2001 |
[Suppressive efffects of clarithromycin and cyclooxygenase-2 inhibitor, etodolac on N-nitrosobis(2-hydroxypropyl)amine(BHP)- induced experimental lung neoplasm in rats].
Topics: Animals; Anti-Bacterial Agents; Carcinoma, Non-Small-Cell Lung; Chronic Disease; Clarithromycin; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Etodolac; Lung Neoplasms; Male; Nitrosamines; Pneumonia; Rats; Rats, Wistar | 2001 |
Chlamydia pneumoniae, clarithromycin, and severe asthma.
Topics: Anti-Bacterial Agents; Asthma; Chlamydophila pneumoniae; Chronic Disease; Clarithromycin; Humans; Pneumonia, Bacterial | 2001 |
[A case of post-tuberculosis chronic empyema with effective low-dose, long-term clarithromycin administration].
Topics: Aged; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Cutaneous Fistula; Empyema; Female; Fistula; Humans; Pleural Diseases; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary | 2001 |
Effect of clarithromycin on chronic respiratory infection caused by Pseudomonas aeruginosa with biofilm formation in an experimental murine model.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Chronic Disease; Clarithromycin; Josamycin; Male; Mice; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Pseudomonas Infections; Respiratory Tract Infections | 2002 |
Detection of Helicobacter pylori colonization in dental plaques and tongue scrapings of patients with chronic gastritis.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Chronic Disease; Clarithromycin; Coloring Agents; Dental Plaque; Drug Therapy, Combination; Female; Fluorescent Dyes; Gastric Mucosa; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Pyloric Antrum; Tongue | 2001 |
Longterm decrease in the CD57 lymphocyte subset in a patient with chronic Lyme disease.
Topics: Adult; Anti-Bacterial Agents; CD57 Antigens; Cefixime; Chronic Disease; Clarithromycin; Female; Humans; Lyme Disease; Lymphocyte Subsets | 2002 |
[Long-term chemotherapy using erythromycin (EM) for chronic lower airway infection: effectiveness of clarithromycin in EM ineffective cases--the fourth report].
Topics: Adult; Aged; Animals; Chronic Disease; Clarithromycin; Drug Administration Schedule; Drug Evaluation; Erythromycin; Female; Humans; Mice; Middle Aged; Respiratory Tract Infections; Time Factors | 1992 |
Activity of clarithromycin alone or in combination with other drugs for treatment of murine toxoplasmosis.
Topics: Acquired Immunodeficiency Syndrome; Acute Disease; Animals; Brain Diseases; Chronic Disease; Clarithromycin; Cysts; Drug Therapy, Combination; Female; Humans; Mice; Mice, Inbred CBA; Pyrimethamine; Sulfadiazine; Toxoplasma; Toxoplasmosis, Animal | 1992 |
[Clarithromycin in the treatment of respiratory infections].
Topics: Bronchitis; Chronic Disease; Clarithromycin; Erythromycin; Humans; Pneumonia; Respiratory Tract Infections | 1991 |